PLIANT THERAPEUTICS I

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

28 فبراير 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Announces Positive Data from Expanded Phase 1b BAL Trial of PLN-74809 Demonstrated Suppression of TGF-β Signaling in Healthy Volunteers

28 فبراير 2022 07:00:01 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis

24 فبراير 2022 16:41:07 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Upcoming Investor Conferences

24 فبراير 2022 07:03:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones

11 يناير 2022 07:03:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference

21 ديسمبر 2021 07:06:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Upcoming Investor Conferences

18 نوفمبر 2021 07:00:02 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

09 نوفمبر 2021 15:06:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Piper Sandler Lung Day

07 أكتوبر 2021 07:06:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis

07 سبتمبر 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Announces Webcast to Present Interim Clinical Data from Ongoing Phase 2a PET Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis

03 سبتمبر 2021 15:10:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

09 أغسطس 2021 15:05:02 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the BTIG Biotechnology Conference

03 أغسطس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

10 مايو 2021 15:21:16 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

05 مايو 2021 07:05:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference

05 أبريل 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

16 مارس 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner

16 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Upcoming Virtual Investor Events

18 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

12 يناير 2021 07:00:01 بحسب Nasdaq GlobeNewswire